Trillium Therapeutics
Utility Patent Applications
Last updated:
List of all Trillium Therapeutics patents 11 in total
| Status | Patent |
|---|---|
Application | Utility: CD47 BLOCKADE WITH PARP INHIBITION FOR DISEASE TREATMENT Filling date: 8 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: CD47 BLOCKADE WITH RADIATION THERAPY Filling date: 8 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS Filling date: 8 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: CD47 BLOCKADE THERAPY WITH CD38 ANTIBODY Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: IMPROVEMENTS IN CD47 BLOCKADE THERAPY BY EGFR ANTIBODY Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS Filling date: 8 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: CD47 BLOCKADE THERAPY Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: HETEROAROMATIC-FUSED IMIDAZOLYL AMIDES, COMPOSITIONS AND USES THEREOF AS STING AGONISTS Filling date: 8 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: HETEROCYCLE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS Filling date: 8 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: IMPROVEMENTS IN CD47 BLOCKADE THERAPY BY HDAC INHIBITORS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Showing 1 to 11 of 11 patents.